Japan’s High-Cost Insurance Payment Cases Soar 21% In Fiscal 2007
This article was originally published in PharmAsia News
Executive Summary
TOKYO - High-cost medical insurance payments that exceed ¥10 million ($93,500) per case and covered by the corporate employers' National Health Insurance policy in fiscal 2007 jumped 20.69 percent to a record 140 cases, the National Federation of Health Insurance Societies reported Sept. 10
You may also be interested in...
Teva And Kowa Partner For 50-50 Stake In Japanese Generic Firm
TOKYO - Japanese drug maker Kowa said Sept. 24 that it had signed a definitive agreement with Israel generic manufacturer Teva Pharmaceutical to share a 50-50 stake in a generic manufacturer in Japan to take advantage of a growing Japanese generics market
Teva And Kowa Partner For 50-50 Stake In Japanese Generic Firm
TOKYO - Japanese drug maker Kowa said Sept. 24 that it had signed a definitive agreement with Israel generic manufacturer Teva Pharmaceutical to share a 50-50 stake in a generic manufacturer in Japan to take advantage of a growing Japanese generics market
Japan’s Corporate Health Insurance Financial Conditions Worsen
TOKYO - Squeezed by soaring treatment costs and shrinking participation, Japan's corporate health insurance providers suffered a steep fall in their balance sheets in fiscal 2007, ended in March 2008, an insurance lobby reported Sept. 10, while predicting that as many as 90 percent of them would suffer operating deficits in fiscal 2008